Boehringer eyes a round of layoffs; Oncothyreon buys a nanoparticle biotech;

@FierceBiotech: ICYMI yesterday: J&J's diabetes combo wins FDA nod in a fast-crowding space. Article | Follow @FierceBiotech

@DamianFierce: Digging into the FDA's priority review voucher. Who's willing to pay big for one? Report | Follow @DamianFierce

@EmilyMFierce: Gene editing method kills cervical cancer cells. More from FierceBiotech Research | Follow @EmilyMFierce

> Boehringer Ingelheim is planning to cut jobs in Germany in an effort to reduce costs by 15%. Story

> Oncothyreon ($ONTY) is trading $27 million for Alpine Biosciences, acquiring a nanoparticle delivery platform with applications in oncology and rare diseases. News

> Federal prosecutors want former SAC Capital Advisors trader Mathew Martoma to forfeit $9.4 million in assets and pay a fine for his role in an insider trading scheme involving Elan ($ELN) and Wyeth's failed Alzheimer's drug bapineuzumab. More

Medical Device News

@FierceMedDev: ICYMI yesterday: Imaging pen may detect skin cancer faster. Article | Follow @FierceMedDev

@StacyALawrence: Med tech M&A gets much, much bigger during the first half. Special report | Follow @StacyALawrence

@VarunSaxena2: ICYMI last week: UPDATED with information from interview of CEO: NeuroPace RNS Stimulator secures add-on payments from CMS. Story | Follow @VarunSaxena2

@EmilyWFierce: Scientists created a 3-D, doughnut-shaped model of the human brain that can imitate neurological function. More from the NYT | Follow @EmilyWFierce

> Lenox MacLaren's grinding court battle with Medtronic will continue. Report

> UCLA researchers develop wearable biosensor for detecting GI disorder postsurgery. More

> Smaller med techs suffer under excise tax burden. Story

> Danish devicemaker homes in on next-generation hearing aid to jump-start sales. Article

Pharma News

@FiercePharma: Tops on FP Monday: Former top Sanofi exec Whitaker nabbed by Synta to shuttle cancer drug to market. Article | Follow @FiercePharma

@EricPFierce: RT @FiercePharma: Boehringer Ingelheim cutting jobs in Germany in 15% cost reduction move. Story | Follow @EricPFierce

@CarlyHFierce: Generic Viagra Delivers Hidden Billionaire Duo in Brazil. Bloomberg story | Follow @CarlyHFierce

> Valeant's No. 3 shareholder: We don't need Allergan. Story

> Boehringer Ingelheim cutting jobs in Germany in 15% cost reduction move. Article

> Syria broadens corruption accusations against GlaxoSmithKline. Report

Biotech Research News

> 3-D bioengineered brain tissue grown in lab. Report

> Small molecule inhibitor reverses cognitive deficits of Alzheimer's in mice. More

> Glaxo: Ebola vaccine could be ready by 2015. Item

> Malaria vaccine alternative shows high protection in mice. Article

> Gene editing method kills cervical cancer cells. Story

Pharma Manufacturing News

> Baxter to add recombinant protein processing suite at Singapore plant. More

> Recalls overseen by FDA soar in 2013, 2014. Item

> Report: Immigrants make up 26% of U.S. drug production and distribution workforce. Story

> Pakistan indicts 76 customs officers in fake drug probe. News

> U.S. health emergency facilities ready to produce Ebola drugs. Article

Suggested Articles

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.

The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based vaccine.

Johnson & Johnson is paying Fate Therapeutics $50 million upfront to collaborate on up to four CAR NK and CAR-T cell therapies.